Chronic Obstructive Pulmonary Disease Clinical Trial
Official title:
Effects of Pulmonary Rehabilitation on Function Cardiovascular, Respiratory and Functional Capacity of People With Chronic Obstructive Pulmonary Disease in the Municipality of Santa Cruz do Sul - Rio Grande do Sul.
The Chronic Obstructive Pulmonary Disease (COPD) has shown a progressive increase of morbidity and mortality, suggesting that the lung as a single therapeutic target, has not contributed in the past 20 years, significant changes to the natural evolution of the disease. Direct treatment for systemic changes and comorbidities, in fact, the most responsible for high rates of treatment failure could mean a new hope of life for individuals with COPD. This research project characterized as interdisciplinary and multidisciplinary program will be headquartered in Pulmonary Rehabilitation of the Santa Cruz Hospital which has partnerships with local companies . Its main objective will be to analyze cardiorespiratory and functional capacity in COPD patients not rehabilitated and rehabilitated after the period from 02 to 12 months of treatment in a Pulmonary Rehabilitation program in the municipality of Santa Cruz do Sul - Rio Grande do Sul. Will be included in this survey of COPD patients who were referred to a rehabilitation program with a clinical diagnosis of disease. In research activities to assess cardiorespiratory and functional capacity of COPD, pre and post-program (02 and 12 months) are provided for Pulmonary Rehabilitation. The research subjects will also be subjected to physical exercise protocol as recommended by the GOLD (2009), a period of eight weeks, often 2x / week, where their vital signs are measured before, during and after each session. Thus, it is believed that it will be possible to refine the knowledge of mechanisms by which the judicious use of pulmonary rehabilitation can control the progression of COPD.
Selection of project participants
COPD, duly diagnosed with proof of spirometric lung function, who are receiving outpatient
care at the Hospital Santa Cruz (HSC) to compose the control group will be selected. For
Rehabilitation Pulmonary Group fase 01 (GRP1) and Rehabilitation Pulmonary Group fase 02
(GRP2) will be selected COPD patients who participate in the program Rehabilitation
Pulmonary occurring within the HSC, in the municipality of Santa Cruz do Sul - Rio Grande do
Sul. The sample size calculation is performed according to the primary endpoint of the
study.
All individuals involved in the project have signed a term of informed consent and answer a
questionnaire of personal health, containing demographic information, exposure to radiation
and drugs, as well as eating habits and consumption of alcohol and cigarettes.
Methodological procedures
The methodological steps of the study will consist of:
1. Selection of subjects according to the criteria of inclusion and exclusion;
2. As an outpatient treatment without Pulmonary Rehabilitation (PR) assess lung volumes,
respiratory muscle strength, dyspnea for Medical Research Council (MRC), functional
capacity for Functional Independence Measurement (MIF) and Six Minutes Walk Test
(6MWT), grip strength, Quality of Life (QoL), body mass index (BMI), and ankle-brachial
index (ITB);
4) As a submission to Rehabilitation Pulmonary after 02 months of treatment to assess lung
volumes, respiratory muscle strength, MRC, functional capacity (MIF and 6MWT), grip
strength, QoL, BMI, and ITB; 5) As a submission in Rehabilitation Pulmonary after 12 months
of treatment to assess lung volumes, respiratory muscle strength, MRC, functional capacity
(MIF and 6MWT), grip strength, QoL, BMI, and ITB
Techniques and tools for collecting
Lung volumes Lung volumes will be assessed through digital spirometry (EasyOne ®, Model
2001, Zurich, Switzerland). It is a tool to provide a record of several volumes and airflows
that an individual is able to mobilize, as the gold standard for assessment of pulmonary
functions according to the International Guidelines of the Global Initiative for Chronic
Obstructive Lung Disease (GOLD, 2011). Forced vital capacity (FVC), forced expiratory volume
in one second (FEV1), forced expiratory flow between 25% and 75% of FVC (FEF 25% -75%),
FEV/FVC relationship, (In the present study, the following variables will be evaluated FEV1
/ FVC) and peak expiratory flow (PEF) (GONTIJO, 2011). Three measures and the curve that
presents the best performance will be compared with the predicted values in the literature
and described in percentage of predicted will be realized (Pereira et al., 1992).
Respiratory Muscle Strength (FMR)
The FMR (MIP and MEP) will be evaluated through digital manometer (MDI®, Porto Alegre,
Brazil). The MIP will be obtained after the individual expiration to residual volume (RV),
the examiner connected with the nose clip and requested inspiration to total lung capacity
(TLC). The MEP will be evaluated after the Total Lung Capacity inspiration to the residual
volume the mouthpiece (ATS, 2002). For data analysis, will be considered the highest value
among the five maneuvers, which did not differ more than 10% of the second highest value in
descending order. These values are then compared with those reported in the literature
(NEDER et al., 1999) and expressed as percentage of predicted. It is noteworthy that for
these measures, the patient will remain in sitting position in the chair or sitting on the
bed with an inclination of 45 °.
Functional dyspnea
The MRC (Medical Research Council), which is a British medical institute, developed a scale
to graduate dyspnea in patients with COPD. The MRC scale is used for decades and has been
adapted into Portuguese and published in published in the II Brazilian Consensus on COPD
(2004). Patients were originally categorized into five grades, ranging from 1 ("normal") to
5 ("very dyspneic to leave the house"). The scale focuses primarily on dyspnoea occurring on
walks. The MRC scale is widely used in patients with COPD due to its simplicity, ease of use
and correlation with quality of life and prognosis.
Functional Capacity
Functional capacity is the independence of an individual to accomplish their mental and
physical activities to maintain their basic and instrumental activities.
The Functional Independence Measure (FIM) is an assessment tool for people in the
rehabilitation process, part of the Uniform Data System for Medical Rehabilitation (SUDRM)
and is widely used and accepted internationally as a measure of functional assessment. Is
linked to mobility and functional capacity in which the individual does not require help to
perform the same, ie, independence supposed to satisfactory performance of motor and
cognitive tasks conditions. The use of the scale focuses on the effective realization of
activities independently in daily routine. So lets documenting their sensitivity to
functional acquisitions and its correlation with functional levels.
The degree of dependence is classified according to the functional independence measure.
This instrument consists of six dimensions: self-care, sphincter control, transfers,
locomotion, communication and social cognition. Each item scores from 1 (total dependence)
to 7 (complete independence). Obtain minimum total score of 18 and maximum of 126 points
that characterize the levels of dependence. Through the individual score will be classified
as follows: mild disability (> 80 points), moderate disability (40-80 points) or severe
disability (<40).
To perform the 6MWT is the standard protocol used ATS Six-Minute Walk Test (2002). The 6MWT
will be held itself, 02 tests, a practice test for educational purposes and another 6MWT,
which will be validated for the collected information of the distance walked in six minutes
and done. Standard phrases of encouragement will be given by the examiner and if necessary,
subjects receive during testing, supplemental oxygen (O2) to maintain a peripheral O2
saturation above 90%.
Dynamometry Manual
Evaluation of peripheral muscle strength by Dynamometry Manual (DM) appears as a simple,
objective, low cost alternative and less invasive to measure maximal voluntary handgrip
strength and its principle to estimate the function of skeletal muscle. The dynamometer is a
device simple to use, and provides fast and direct reading. This test enables indicating
health risks related to muscle strength and correlated to other skeletal muscles in the
human body, and is considered a good indicator for the overall muscle strength and also to
assess physical performance in several clinical situations. Conform the American Society of
Hand Therapist (ASHT), for measuring handgrip, patients should be seated comfortably with
adducted and neutrally rotated, elbow flexed at 90 °, with arm in neutral
pronation-supination and shoulder wrist joint between 0 ° and 30 ° of extension. The
procedure should be performed three times in both limbs (right and left) the average of the
measurements of each hemibody being calculated separately and given a resting time of 60
seconds between ume measurement and another quoted by.
Quality of Life (QOL)
The questionnaire St. George's Respiratory Questionnaire (SGRQ) which is specific for the
assessment of QoL in patients with COPD will be used. This questionnaire consists of 76
items and is divided into 03 domains (symptoms, activity and impact of the disease). For
each domain, the items are coded and transformed into a scale of zero (worst QOL) to 100
points (best QoL), according to the standardization of the Manual.
Anthropometric Assessment
The most widely used anthropometric measurements to assess nutritional status are: weight,
height, circumferences (arm and waist), arm length and skinfold thicknesses (triceps,
biceps, subscapular, suprailiac). Through the combination of these measures is possible to
calculate the weight / height, arm muscle circumference and arm fat index relationships.
Anthropometric measurements are easy to perform and relatively sensitive to evaluate adult
patients hospitalized in isolation as malnutrition. The body mass index (BMI), expressed as
the relationship between body mass in kg and height in m2, is widely used as an indicator of
nutritional status for its good correlation with body mass and low correlation with height.
Ankle-Brachial Index (ABI)
The ABI is a noninvasive measurement of peripheral arterial disease is highly predictive of
subsequent cardiovascular morbidity and mortality in hypertensive patients. It is the
relationship between the (maximum) of the ankle systolic blood pressure (right and left) and
the (maximum) arm systolic blood pressure (right and left) with the patient at rest which is
taken as a reference the largest value observed among measured the sides. Gauging the
(maximum) systolic blood pressure of lower limbs is taken through the ankle being performed
using a Doppler Vascular Portable and upper limbs with a sphygmomanometer. It will be noted
that the ankle pressure is generally higher, then a ratio of 1 to 1.1 is normal. It is
noteworthy that a lower index 0.9 provides strong evidence of peripheral arterial disease,
thus the lower the value, the more severe the disease, as this reduction is due to the
presence of arterial obstruction in the lower limb. This index is strongly associated with
the incidence of strongly related to the individual's functional capacity Arterial Chronic
Disease.
Waist-Hip Ratio (WHR)
To obtain the WHR, the waist is measured at the narrowest part of the waist, between the
last rib and the iliac crest and hip circumference is taken at the widest area of the hips
and the largest protuberance of the buttocks. Then divide the waist measurement by the hip
measurement. WHO defines the indices of> 9.0 in men and> 8.5 in women as a crucial
relationship to the metabolic syndrome. Studies confirm and cite several other studies that
show that WHR is superior to predict all-cause and cardiovascular disease mortality clinical
measure. Another Study add that the hip circumference indicates a lower risk of body fat
accumulation and thus include it in the waist-hip ratio equation improves the accuracy of
the measurement technique.
Lactate analysis
In conjunction with the 6MWT, the measure of capillary lactate could estimate muscle
metabolism profile of COPD patients, since his early increase before the physical exertion
seems to be associated with changes in muscle metabolism, observable loss of oxidative
activity of skeletal muscle . The measurement will be performed after obtaining a drop of
capillary blood from the tip of the second finger of the nondominant hand for analysis of
lactate at rest and after the 6MWT, the pre-Rehabilitation Pulmonary intervals, 02, and 12
months post-Rehabilitation Pulmonary, (Lct) on the in lactate analyzer Accutrend Plus.
Intervention procedures
The group of patients undergoing Rehabilitation Pulmonary will carry out the intervention
protocol as recommended by the GOLD (2009). Will undergo submaximal aerobic training for
30-40 minutes strength training for upper and lower limbs, muscle stretching, nutritional
and pharmacological monitoring and continuing education sessions, twice a week. Such
measures will be carried out under the Hospital Santa Cruz, Santa Cruz do Sul - Rio Grande
do Sul.
;
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05102305 -
A Multi-center,Prospective, OS to Evaluate the Effectiveness of 'NAC' Nebulizer Therapy in COPD (NEWEST)
|
||
Completed |
NCT01867762 -
An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Recruiting |
NCT05562037 -
Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA
|
N/A | |
Terminated |
NCT04921332 -
Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD
|
N/A | |
Completed |
NCT03089515 -
Small Airway Chronic Obstructive Disease Syndrome Following Exposure to WTC Dust
|
N/A | |
Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
Recruiting |
NCT05552833 -
Pulmonary Adaptive Responses to HIIT in COPD
|
N/A | |
Recruiting |
NCT05835492 -
A Pragmatic Real-world Multicentre Observational Research Study to Explore the Clinical and Health Economic Impact of myCOPD
|
||
Recruiting |
NCT05631132 -
May Noninvasive Mechanical Ventilation (NIV) and/or Continuous Positive Airway Pressure (CPAP) Increase the Bronchoalveolar Lavage (BAL) Salvage in Patients With Pulmonary Diseases?
|
N/A | |
Completed |
NCT03244137 -
Effects of Pulmonary Rehabilitation on Cognitive Function in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease
|
||
Not yet recruiting |
NCT03282526 -
Volume Parameters vs Flow Parameters in Assessment of Reversibility in Chronic Obstructive Pulmonary Disease
|
N/A | |
Completed |
NCT02546700 -
A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 2 | |
Withdrawn |
NCT04446637 -
Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPD
|
Phase 3 | |
Completed |
NCT04535986 -
A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD
|
Phase 3 | |
Recruiting |
NCT05865184 -
Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
|
||
Completed |
NCT03295474 -
Telemonitoring in Pulmonary Rehabilitation: Feasibility and Acceptability of a Remote Pulse Oxymetry System.
|
||
Completed |
NCT03256695 -
Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Withdrawn |
NCT04042168 -
Implications of Appropriate Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
Completed |
NCT03414541 -
Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Completed |
NCT02552160 -
DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy
|